Physician profile
Sunjoo Oh
NPI 1376353961
$2,472.47
in general payments reported to CMS, 2019-2025
18 companies · $2,472 in 2025
The $2,472 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,472.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $900.50 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $438.28 | 2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $284.06 | 2025 | Xifaxan |
| Janssen Biotech, INC. | $204.80 | 2025 | Tremfya, Stelara, Simponi Aria |
| Madrigal Pharmaceuticals | $101.04 | 2025 | Rezdiffra |
| Celltrion USA INC. | $89.41 | 2025 | Vegzelma |
| Ipsen Biopharmaceuticals, INC | $83.93 | 2025 | Iqirvo |
| Neuraxis, INC. | $77.59 | 2025 | |
| Lilly USA, LLC | $48.90 | 2025 | Omvoh |
| Evoke Pharma, INC. | $46.77 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $38.79 | 2025 | Dupixent |
| Genzyme Corporation | $36.74 | 2025 | |
| Ardelyx, INC. | $33.48 | 2025 | Ibsrela |
| Qol Medical, LLC | $29.42 | 2025 | Sucraid |
| Aimmune Therapeutics, INC. | $16.75 | 2025 | Zenpep |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $15.99 | 2025 | Vemlidy |
| Intercept Pharmaceuticals, INC. | $15.38 | 2025 | |
| Phathom Pharmaceuticals, INC. | $10.64 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunjoo Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.